Dongwang Zhu

2.0k total citations
56 papers, 1.5k citations indexed

About

Dongwang Zhu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dongwang Zhu has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Dongwang Zhu's work include Cancer-related molecular mechanisms research (9 papers), Head and Neck Cancer Studies (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dongwang Zhu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Head and Neck Cancer Studies (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dongwang Zhu collaborates with scholars based in China, United States and Nigeria. Dongwang Zhu's co-authors include Xueyi Dong, Xiulan Zhao, Yanhui Zhang, Lai‐ping Zhong, Tieju Liu, Meili Wang, Baocun Sun, Fang Liu, Qiang Gu and Danfang Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Dongwang Zhu

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongwang Zhu China 23 805 511 371 224 174 56 1.5k
Shuyang Sun China 25 884 1.1× 354 0.7× 502 1.4× 319 1.4× 181 1.0× 46 1.6k
Wiktoria Maria Suchorska Poland 23 829 1.0× 478 0.9× 386 1.0× 205 0.9× 219 1.3× 112 1.8k
Xi Yang China 23 824 1.0× 283 0.6× 362 1.0× 130 0.6× 164 0.9× 62 1.8k
Miao Deng China 22 616 0.8× 337 0.7× 393 1.1× 294 1.3× 144 0.8× 68 1.3k
Donghai Huang China 24 815 1.0× 377 0.7× 380 1.0× 83 0.4× 144 0.8× 60 1.3k
Anxun Wang China 21 799 1.0× 352 0.7× 247 0.7× 131 0.6× 73 0.4× 34 1.2k
Wantao Chen China 24 1.2k 1.5× 948 1.9× 410 1.1× 69 0.3× 147 0.8× 46 1.8k
Laikui Liu China 27 1.1k 1.4× 506 1.0× 731 2.0× 142 0.6× 341 2.0× 72 2.2k
Fanglong Wu China 18 607 0.8× 411 0.8× 529 1.4× 125 0.6× 303 1.7× 42 1.4k
Yun Zhu China 23 522 0.6× 244 0.5× 253 0.7× 409 1.8× 113 0.6× 63 1.3k

Countries citing papers authored by Dongwang Zhu

Since Specialization
Citations

This map shows the geographic impact of Dongwang Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwang Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwang Zhu more than expected).

Fields of papers citing papers by Dongwang Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwang Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwang Zhu. The network helps show where Dongwang Zhu may publish in the future.

Co-authorship network of co-authors of Dongwang Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwang Zhu. A scholar is included among the top collaborators of Dongwang Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwang Zhu. Dongwang Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hui, et al.. (2025). Prognostic value of the pretreatment Naples prognostic score in patients with colorectal cancer: a systematic review and meta-analysis. Frontiers in Oncology. 14. 1498854–1498854. 5 indexed citations
2.
Liu, Ying, Limin Liu, Wen Jiang, et al.. (2024). Nomogram to Predict Nodal Recurrence‐Free Survival in Early Oral Squamous Cell Carcinoma. Oral Diseases. 31(3). 718–728.
3.
Zhong, Lai‐ping, Zhihang Zhou, Yi Lu, et al.. (2024). Associations of ctDNA clearance and pathological response after neoadjuvant treatment in patients with locally advanced oral cancer.. Journal of Clinical Oncology. 42(16_suppl). 6043–6043. 1 indexed citations
4.
Ju, Wu‐tong, Ying Liu, Jingjing Sun, et al.. (2023). Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study. International Journal of Surgery. 109(4). 879–886. 2 indexed citations
5.
Ju, Wu‐tong, Ronghui Xia, Dongwang Zhu, et al.. (2022). A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nature Communications. 13(1). 78 indexed citations
6.
Huang, Yingying, Jun Li, Dongwang Zhu, et al.. (2022). Neoadjuvant Immunochemotherapy for Locally Advanced Resectable Oral Squamous Cell Carcinoma: A Prospective Single-Arm Trial. SSRN Electronic Journal. 1 indexed citations
7.
Zhong, Jiayong, Zhihang Zhou, Yuhua Hu, et al.. (2022). Diagnosis and management of hypoglossal nerve-derived schwannoma in the floor of mouth: a case series. BMC Oral Health. 22(1). 265–265. 3 indexed citations
8.
Sun, Wenwen, Tongchao Zhao, Timothy Aladelusi, et al.. (2021). Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 50(8). 795–802. 3 indexed citations
9.
Zhu, Dongwang, et al.. (2020). Hyaluronic Acid/Parecoxib-Loaded PLGA Microspheres for Therapy of Temporomandibular Disorders. Current Drug Delivery. 18(2). 234–245. 14 indexed citations
10.
Zhao, Tongchao, Siyuan Liang, Wu‐tong Ju, et al.. (2019). Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma. Clinical Nutrition. 39(9). 2751–2758. 8 indexed citations
11.
Xu, Hongyuan, Dongwang Zhu, Lai‐ping Zhong, et al.. (2019). Effects of insulin-like growth factor binding protein 3 on cell growth and tumorigenesis in oral squamous cell carcinoma. Translational Cancer Research. 8(5). 1709–1717. 1 indexed citations
12.
Sun, Xiao, Guilong Zhang, Rui Xu, et al.. (2018). A biodegradable MnSiO3@Fe3O4 nanoplatform for dual-mode magnetic resonance imaging guided combinatorial cancer therapy. Biomaterials. 194. 151–160. 98 indexed citations
13.
Yang, Jie, Kai Zhang, Kehua Que, et al.. (2018). Surface modification of titanium with hydroxyapatite layer induced by phase-transited lysozyme coating. Materials Science and Engineering C. 92. 206–215. 32 indexed citations
14.
Liu, Tieju, Huizhi Sun, Dongwang Zhu, et al.. (2017). TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing. Molecular Cancer Therapeutics. 16(7). 1377–1388. 40 indexed citations
15.
Sun, Huizhi, Tieju Liu, Dongwang Zhu, et al.. (2017). HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases. Genes Chromosomes and Cancer. 56(8). 598–607. 38 indexed citations
16.
Wang, Yong, Baocun Sun, Xiulan Zhao, et al.. (2016). Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma. Oncotarget. 7(17). 24383–24401. 46 indexed citations
17.
Nesvick, Cody L., Chao Zhang, Nancy A. Edwards, et al.. (2016). ZEB1 expression is increased in IDH1-mutant lower-grade gliomas. Journal of Neuro-Oncology. 130(1). 111–122. 14 indexed citations
18.
Li, Yanlei, Baocun Sun, Xiulan Zhao, et al.. (2015). Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer. Experimental and Molecular Pathology. 98(2). 136–144. 16 indexed citations
19.
Yang, Cuixia, Jun Ma, Dongwang Zhu, et al.. (2014). GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. Annals of Oncology. 25(6). 1215–1222. 52 indexed citations
20.
Zhu, Dongwang, Xiao Yang, Chengzhe Yang, et al.. (2013). Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade. Oral Oncology. 49(6). 542–550. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuyang Sun Breakdown of academic impact, for papers by Wiktoria Maria Suchorska Breakdown of academic impact, for papers by Xi Yang Breakdown of academic impact, for papers by Miao Deng Breakdown of academic impact, for papers by Donghai Huang Breakdown of academic impact, for papers by Anxun Wang Breakdown of academic impact, for papers by Wantao Chen Breakdown of academic impact, for papers by Laikui Liu Breakdown of academic impact, for papers by Fanglong Wu Breakdown of academic impact, for papers by Yun Zhu
Rankless by CCL
2026